Beyond the First Cancer: Secondary Malignancies Associated With Soft Tissue Sarcomas.
BackgroundAdvances in treatment as well as personalized treatment options based on mutational analysis have led to increased survival for patients with soft tissue sarcomas (STSs). Given improved outcomes, patients are at risk of developing a secondary malignancy. There is a paucity of data in patients with STS and the...